Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymosin Beta 4 in Venous Stasis Ulcers
NCT00832091Phase 2Completed
- Sponsor
- RegeneRx Biopharmaceuticals, Inc.
- Start
- Jul 2006
- Primary completion
- Jan 2009
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of thymosin beta-4 in venous stasis ulcer, sponsored by RegeneRx Biopharmaceuticals, Inc.. Started Jul 2006; status: completed.
02
Drugs
thymosin beta-4
03
Conditions
venous stasis ulcer
Beyond the preview
Go deeper on NCT00832091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00832091.